MedPath

The Impact of Repetitive Transcranial Magnetic Stimulation on the Prognosis of Elderly Surgical Patients

Not Applicable
Completed
Conditions
Postoperative Cognitive Dysfunction
Postoperative Delirium
Chronic Post-surgical Pain
Interventions
Device: Repetitive Transcranial Magnetic Stimulation
Registration Number
NCT06392919
Lead Sponsor
Affiliated Hospital of Nantong University
Brief Summary

Exploring the effects of repeated transcranial magnetic stimulation (rTMS) during the perioperative period on the incidence of postoperative delirium, postoperative cognitive dysfunction, and chronic postoperative pain in elderly patients, as well as its possible mechanisms.

Detailed Description

Patients are recruited one week prior to the trial commencement, during which they are informed about the experimental protocol and associated risks. After obtaining informed consent and signatures, they are enrolled as study participants.Patients who meet the trial criteria are randomly assigned in a 1:1 ratio to the control group (sham rTMS group) and the intervention group (rTMS group, with rTMS intervention applied in the PACU after surgery) in a double-blind manner (with rTMS intervention and postoperative follow-up conducted by different researchers).

Note: This trial includes three co-primary outcomes-postoperative delirium (POD), postoperative cognitive dysfunction (POCD), and chronic postoperative pain (CPSP). To account for the different nature and timelines of these outcomes, the study was designed to include two parallel patient cohorts under a unified protocol:

1. Elderly patients undergoing gastrointestinal surgery are enrolled primarily for the evaluation of POD, a short-term outcome assessed within 3 days postoperatively.

2. Elderly patients undergoing thoracic surgery are enrolled to evaluate POCD (at 1 month) and CPSP (at 3 months), which are longer-term outcomes.

These two patient cohorts are studied concurrently but analyzed separately according to outcome-specific follow-up timelines and sample size estimations. A total of 122 gastrointestinal surgery patients were enrolled and analyzed for POD. The maximum estimated sample size is for the POCD and CPSP cohort (n=230). Results will be reported in phases corresponding to the completion of each outcome assessment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
352
Inclusion Criteria
  • Age ≥ 60 years;
  • ASA ≤ 3;
  • Elective surgery patients.
Exclusion Criteria
  • Refusal to sign the consent form;
  • Mini-Mental State Examination (MMSE) score < 15;
  • Preoperative neuropsychiatric diseases and history of neurological or psychiatric disorders;
  • Preoperative cranial or scalp injuries;
  • History of drug or alcohol abuse; Visual or auditory impairments, communication difficulties; Presence of metallic implants in the body; Preoperative history of severe cardiovascular disease or severe liver or kidney dysfunction.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
repetitive transcranial magnetic stimulation (rTMS group)Repetitive Transcranial Magnetic StimulationAfter the surgical anesthesia, the patient is transferred to the Post-Anesthesia Care Unit (PACU). The rTMS intervention occurs after the tracheal tube is removed in the PACU. The stimulation site is the DLPFC (left dorsolateral prefrontal cortex); the stimulation intensity is 100% of the Resting Motor Threshold (RMT); the frequency is 10 Hz; and the total number of pulses is 2000. The pulse characteristics include a duration of 5 seconds per session with a 25-second interval between sessions.
Primary Outcome Measures
NameTimeMethod
Incidence of chronic postsurgical pain (CPSP) at 3 months after surgeryAt 3 months after surgery

CPSP is defined as pain persisting for at least three months after surgery that was not present before surgery or that had different characteristics, and other possible causes of pain were excluded (e.g., cancer recurrence, infection). Pain intensity is assessed with the numeric rating scale, an 11-point scale where 0=no pain and 10=the worst pain, both at rest and with movement.

Incidence of delirium during the first 3 days after surgeryThe first 3 days after surgery

Delirium is assessed twice daily (8-10 AM and 6-8 PM) with the Confusion Assessment Method for patients without endotracheal intubation during the first 3 days after surgery.

Incidence of Postoperative Cognitive Dysfunction1 month after surgery

Cognitive function assessed with MoCA (Montreal Cognitive Assessment) test on the 30th day after surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Affiliated hospital of Nantong University

🇨🇳

Nantong, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath